Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

GM Helix Acqua Implant,Ti,4.0X16: medical device reports filed with FDA

838 reports name it, 2019–2026. Manufacturer given most often on reports: Jjgc. Product code DZE.

838
device reports naming the brand
0% of all MAUDE reports · about 121 a year
293
reports, 12 months to August 2026
161 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 838 reports that name the brand "GM Helix Acqua Implant,Ti,4.0X16" (endosseous dental implant), received between August 2019 and August 2026; the manufacturer given most often on reports is Jjgc. Spellings of one product vary from report to report.

293 reports arrived in the 12 months to August 2026, up 82% from 161 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (72.3%), loss of osseointegration (18.9%) and fracture (0.2%). The patient problems coded most often are pain, fibrosis and hemorrhage/blood loss/bleeding. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

02550Sep 2021: 14Oct 2021: 2Nov 2021: 4Dec 2021: 32022Jan 2022: 4Feb 2022: 7Mar 2022: 2Apr 2022: 1May 2022: 10Jun 2022: 6Jul 2022: 9Aug 2022: 11Sep 2022: 8Oct 2022: 9Nov 2022: 10Dec 2022: 62023Jan 2023: 9Feb 2023: 4Mar 2023: 14Apr 2023: 10May 2023: 14Jun 2023: 15Jul 2023: 5Aug 2023: 10Sep 2023: 5Oct 2023: 8Nov 2023: 10Dec 2023: 172024Jan 2024: 15Feb 2024: 14Mar 2024: 8Apr 2024: 16May 2024: 13Jun 2024: 10Jul 2024: 20Aug 2024: 6Sep 2024: 17Oct 2024: 7Nov 2024: 10Dec 2024: 162025Jan 2025: 8Feb 2025: 13Mar 2025: 5Apr 2025: 8May 2025: 0Jun 2025: 40Jul 2025: 23Aug 2025: 14Sep 2025: 23Oct 2025: 16Nov 2025: 19Dec 2025: 152026Jan 2026: 24Feb 2026: 19Mar 2026: 50Apr 2026: 22May 2026: 16Jun 2026: 31Jul 2026: 27Aug 2026: 31

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

01102202019: 520192020: 2620202021: 4720212022: 8320222023: 12120232024: 15220242025: 18420252026: 2202026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%838
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report84.5%708
Voluntary report0%0
User facility report0%0
Distributor report15.5%130
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate60672.3%62.8%
Loss of osseointegration15818.9%22.4%
Fracturea broken bone20.2%1.6%
Difficult to insertthe device was hard to insert10.1%0.4%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Painpain, site not specified23127.6%
Fibrosis20023.9%
Hemorrhage/blood loss/bleeding546.4%
Inflammationinflammation364.3%
Swelling/ edema354.2%
Hyperresponsive to stimuli273.2%
Fistula212.5%
Abscessa collection of pus111.3%
Hypersensitivity/allergic reaction111.3%
Tissue damage101.2%
Sinus perforation60.7%
Failure of implant20.2%
Inadequate osseointegration10.1%
Numbnessnumbness10.1%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureGM Helix Acqua Implant,Ti,4.0X16Product code DZEAll MAUDE reports
Reports8383,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer84.5%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about GM Helix Acqua Implant,Ti,4.0X16 reports

How many FDA reports name GM Helix Acqua Implant,Ti,4.0X16?

838 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 293 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (72.3%), loss of osseointegration (18.9%), fracture (0.2%) and difficult to insert (0.1%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (84.5%) and distributor reports (15.5%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that GM Helix Acqua Implant,Ti,4.0X16 was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.